SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
NCT05935384
·
clinicaltrials.gov ↗
RECRUITING
Status
470
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-small Cell Lung Cancer
Colorectal Cancer
Breast Cancer
Interventions
DIAGNOSTIC_TEST:
Guardant360
Sponsor
Guardant Health, Inc.